Loading…

Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies

Abstract Retinoic acid-inducible gene I (RIG-I) recognizes double-stranded viral RNAs (dsRNAs) containing two or three 5′ phosphates. A few reports of 5′-PPP-independent RIG-I agonists have emerged, but little is known about the molecular principles underlying their recognition. We recently found th...

Full description

Saved in:
Bibliographic Details
Published in:Nucleic acids research 2018-02, Vol.46 (4), p.1635-1647
Main Authors: Lee, Janghyun, Park, Eun-Byeol, Min, Jiyoun, Sung, Si-Eun, Jang, Yejin, Shin, Jin Soo, Chun, Dongmin, Kim, Ki-Hun, Hwang, Jihyun, Lee, Mi-Kyung, Go, Yun Young, Kwon, Dohyeong, Kim, Meehyein, Kang, Suk-Jo, Choi, Byong-Seok
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3
cites cdi_FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3
container_end_page 1647
container_issue 4
container_start_page 1635
container_title Nucleic acids research
container_volume 46
creator Lee, Janghyun
Park, Eun-Byeol
Min, Jiyoun
Sung, Si-Eun
Jang, Yejin
Shin, Jin Soo
Chun, Dongmin
Kim, Ki-Hun
Hwang, Jihyun
Lee, Mi-Kyung
Go, Yun Young
Kwon, Dohyeong
Kim, Meehyein
Kang, Suk-Jo
Choi, Byong-Seok
description Abstract Retinoic acid-inducible gene I (RIG-I) recognizes double-stranded viral RNAs (dsRNAs) containing two or three 5′ phosphates. A few reports of 5′-PPP-independent RIG-I agonists have emerged, but little is known about the molecular principles underlying their recognition. We recently found that the bent duplex RNA from the influenza A panhandle promoter activates RIG-I even in the absence of a 5′-triphosphate moiety. Here, we report that non-canonical synthetic RNA oligonucleotides containing G-U wobble base pairs that form a bent helix can exert RIG-I-mediated antiviral and anti-tumor effects in a sequence- and site-dependent manner. We present synthetic RNAs that have been systematically modified to enhance their efficacy and we outline the basic principles for engineering RIG-I agonists applicable to immunotherapy.
doi_str_mv 10.1093/nar/gky039
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5829749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/nar/gky039</oup_id><sourcerecordid>1992013370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3</originalsourceid><addsrcrecordid>eNp9kUFrHCEUxyW0NJukl3yA4qUQAtPoqLPjpRBCmyyEFpL2LK4-N7YzOlUnsN--JpuE9FI8PJ_--L0Hf4SOKflEiWRnQaezze8tYXIPLSjr2obLrn2DFoQR0VDC-310kPMvQiingr9D-61ky3rEAsXbbS4w6uINBuuLDxscHc7bUO7g4fFmddms8OA3OtiMS8RTinY2gME5MMXfA9ahFp_0UG_2sWvKPMaEb76dYz-Oc4hVlvTkIR-ht04PGd4_1UP08-uXHxdXzfX3y9XF-XVjOOlLYzq5dM623Ih2DZy2RKxdJzqwTHaid643llpmQRjDQRNpQHaS95RXmEtgh-jzzjvN6xGsgVDqgmpKftRpq6L26t-f4O_UJt4r0bdyyWUVnDwJUvwzQy5q9NnAMOgAcc6KStkSytiSVPR0h5oUc07gXsZQoh4SUjUhtUuowh9eL_aCPkdSgY87IM7T_0R_AQf4nSY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1992013370</pqid></control><display><type>article</type><title>Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies</title><source>Oxford University Press</source><source>PubMed Central</source><creator>Lee, Janghyun ; Park, Eun-Byeol ; Min, Jiyoun ; Sung, Si-Eun ; Jang, Yejin ; Shin, Jin Soo ; Chun, Dongmin ; Kim, Ki-Hun ; Hwang, Jihyun ; Lee, Mi-Kyung ; Go, Yun Young ; Kwon, Dohyeong ; Kim, Meehyein ; Kang, Suk-Jo ; Choi, Byong-Seok</creator><creatorcontrib>Lee, Janghyun ; Park, Eun-Byeol ; Min, Jiyoun ; Sung, Si-Eun ; Jang, Yejin ; Shin, Jin Soo ; Chun, Dongmin ; Kim, Ki-Hun ; Hwang, Jihyun ; Lee, Mi-Kyung ; Go, Yun Young ; Kwon, Dohyeong ; Kim, Meehyein ; Kang, Suk-Jo ; Choi, Byong-Seok</creatorcontrib><description>Abstract Retinoic acid-inducible gene I (RIG-I) recognizes double-stranded viral RNAs (dsRNAs) containing two or three 5′ phosphates. A few reports of 5′-PPP-independent RIG-I agonists have emerged, but little is known about the molecular principles underlying their recognition. We recently found that the bent duplex RNA from the influenza A panhandle promoter activates RIG-I even in the absence of a 5′-triphosphate moiety. Here, we report that non-canonical synthetic RNA oligonucleotides containing G-U wobble base pairs that form a bent helix can exert RIG-I-mediated antiviral and anti-tumor effects in a sequence- and site-dependent manner. We present synthetic RNAs that have been systematically modified to enhance their efficacy and we outline the basic principles for engineering RIG-I agonists applicable to immunotherapy.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/gky039</identifier><identifier>PMID: 29373735</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Chemical Biology and Nucleic Acid Chemistry</subject><ispartof>Nucleic acids research, 2018-02, Vol.46 (4), p.1635-1647</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3</citedby><cites>FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829749/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829749/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,1591,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29373735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Janghyun</creatorcontrib><creatorcontrib>Park, Eun-Byeol</creatorcontrib><creatorcontrib>Min, Jiyoun</creatorcontrib><creatorcontrib>Sung, Si-Eun</creatorcontrib><creatorcontrib>Jang, Yejin</creatorcontrib><creatorcontrib>Shin, Jin Soo</creatorcontrib><creatorcontrib>Chun, Dongmin</creatorcontrib><creatorcontrib>Kim, Ki-Hun</creatorcontrib><creatorcontrib>Hwang, Jihyun</creatorcontrib><creatorcontrib>Lee, Mi-Kyung</creatorcontrib><creatorcontrib>Go, Yun Young</creatorcontrib><creatorcontrib>Kwon, Dohyeong</creatorcontrib><creatorcontrib>Kim, Meehyein</creatorcontrib><creatorcontrib>Kang, Suk-Jo</creatorcontrib><creatorcontrib>Choi, Byong-Seok</creatorcontrib><title>Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies</title><title>Nucleic acids research</title><addtitle>Nucleic Acids Res</addtitle><description>Abstract Retinoic acid-inducible gene I (RIG-I) recognizes double-stranded viral RNAs (dsRNAs) containing two or three 5′ phosphates. A few reports of 5′-PPP-independent RIG-I agonists have emerged, but little is known about the molecular principles underlying their recognition. We recently found that the bent duplex RNA from the influenza A panhandle promoter activates RIG-I even in the absence of a 5′-triphosphate moiety. Here, we report that non-canonical synthetic RNA oligonucleotides containing G-U wobble base pairs that form a bent helix can exert RIG-I-mediated antiviral and anti-tumor effects in a sequence- and site-dependent manner. We present synthetic RNAs that have been systematically modified to enhance their efficacy and we outline the basic principles for engineering RIG-I agonists applicable to immunotherapy.</description><subject>Chemical Biology and Nucleic Acid Chemistry</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kUFrHCEUxyW0NJukl3yA4qUQAtPoqLPjpRBCmyyEFpL2LK4-N7YzOlUnsN--JpuE9FI8PJ_--L0Hf4SOKflEiWRnQaezze8tYXIPLSjr2obLrn2DFoQR0VDC-310kPMvQiingr9D-61ky3rEAsXbbS4w6uINBuuLDxscHc7bUO7g4fFmddms8OA3OtiMS8RTinY2gME5MMXfA9ahFp_0UG_2sWvKPMaEb76dYz-Oc4hVlvTkIR-ht04PGd4_1UP08-uXHxdXzfX3y9XF-XVjOOlLYzq5dM623Ih2DZy2RKxdJzqwTHaid643llpmQRjDQRNpQHaS95RXmEtgh-jzzjvN6xGsgVDqgmpKftRpq6L26t-f4O_UJt4r0bdyyWUVnDwJUvwzQy5q9NnAMOgAcc6KStkSytiSVPR0h5oUc07gXsZQoh4SUjUhtUuowh9eL_aCPkdSgY87IM7T_0R_AQf4nSY</recordid><startdate>20180228</startdate><enddate>20180228</enddate><creator>Lee, Janghyun</creator><creator>Park, Eun-Byeol</creator><creator>Min, Jiyoun</creator><creator>Sung, Si-Eun</creator><creator>Jang, Yejin</creator><creator>Shin, Jin Soo</creator><creator>Chun, Dongmin</creator><creator>Kim, Ki-Hun</creator><creator>Hwang, Jihyun</creator><creator>Lee, Mi-Kyung</creator><creator>Go, Yun Young</creator><creator>Kwon, Dohyeong</creator><creator>Kim, Meehyein</creator><creator>Kang, Suk-Jo</creator><creator>Choi, Byong-Seok</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180228</creationdate><title>Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies</title><author>Lee, Janghyun ; Park, Eun-Byeol ; Min, Jiyoun ; Sung, Si-Eun ; Jang, Yejin ; Shin, Jin Soo ; Chun, Dongmin ; Kim, Ki-Hun ; Hwang, Jihyun ; Lee, Mi-Kyung ; Go, Yun Young ; Kwon, Dohyeong ; Kim, Meehyein ; Kang, Suk-Jo ; Choi, Byong-Seok</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Chemical Biology and Nucleic Acid Chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Janghyun</creatorcontrib><creatorcontrib>Park, Eun-Byeol</creatorcontrib><creatorcontrib>Min, Jiyoun</creatorcontrib><creatorcontrib>Sung, Si-Eun</creatorcontrib><creatorcontrib>Jang, Yejin</creatorcontrib><creatorcontrib>Shin, Jin Soo</creatorcontrib><creatorcontrib>Chun, Dongmin</creatorcontrib><creatorcontrib>Kim, Ki-Hun</creatorcontrib><creatorcontrib>Hwang, Jihyun</creatorcontrib><creatorcontrib>Lee, Mi-Kyung</creatorcontrib><creatorcontrib>Go, Yun Young</creatorcontrib><creatorcontrib>Kwon, Dohyeong</creatorcontrib><creatorcontrib>Kim, Meehyein</creatorcontrib><creatorcontrib>Kang, Suk-Jo</creatorcontrib><creatorcontrib>Choi, Byong-Seok</creatorcontrib><collection>OUP_牛津大学出版社OA刊</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Janghyun</au><au>Park, Eun-Byeol</au><au>Min, Jiyoun</au><au>Sung, Si-Eun</au><au>Jang, Yejin</au><au>Shin, Jin Soo</au><au>Chun, Dongmin</au><au>Kim, Ki-Hun</au><au>Hwang, Jihyun</au><au>Lee, Mi-Kyung</au><au>Go, Yun Young</au><au>Kwon, Dohyeong</au><au>Kim, Meehyein</au><au>Kang, Suk-Jo</au><au>Choi, Byong-Seok</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucleic Acids Res</addtitle><date>2018-02-28</date><risdate>2018</risdate><volume>46</volume><issue>4</issue><spage>1635</spage><epage>1647</epage><pages>1635-1647</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Correction/Retraction-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><notes>Mi-Kyung Lee, Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, South Korea.</notes><notes>These authors contributed equally to this work as first authors.</notes><notes>Present addresses</notes><notes>Jiyoun Min, Drug Discovery Center, Life Sciences R&amp;D, E8 Block LG Science Park, 30 Magokjungang 10-ro, Gangseo-gu, Seoul, 07796, South Korea.</notes><abstract>Abstract Retinoic acid-inducible gene I (RIG-I) recognizes double-stranded viral RNAs (dsRNAs) containing two or three 5′ phosphates. A few reports of 5′-PPP-independent RIG-I agonists have emerged, but little is known about the molecular principles underlying their recognition. We recently found that the bent duplex RNA from the influenza A panhandle promoter activates RIG-I even in the absence of a 5′-triphosphate moiety. Here, we report that non-canonical synthetic RNA oligonucleotides containing G-U wobble base pairs that form a bent helix can exert RIG-I-mediated antiviral and anti-tumor effects in a sequence- and site-dependent manner. We present synthetic RNAs that have been systematically modified to enhance their efficacy and we outline the basic principles for engineering RIG-I agonists applicable to immunotherapy.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>29373735</pmid><doi>10.1093/nar/gky039</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-1048
ispartof Nucleic acids research, 2018-02, Vol.46 (4), p.1635-1647
issn 0305-1048
1362-4962
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5829749
source Oxford University Press; PubMed Central
subjects Chemical Biology and Nucleic Acid Chemistry
title Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T10%3A37%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systematic%20editing%20of%20synthetic%20RIG-I%20ligands%20to%20produce%20effective%20antiviral%20and%20anti-tumor%20RNA%20immunotherapies&rft.jtitle=Nucleic%20acids%20research&rft.au=Lee,%20Janghyun&rft.date=2018-02-28&rft.volume=46&rft.issue=4&rft.spage=1635&rft.epage=1647&rft.pages=1635-1647&rft.issn=0305-1048&rft.eissn=1362-4962&rft_id=info:doi/10.1093/nar/gky039&rft_dat=%3Cproquest_pubme%3E1992013370%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-c697ffd24c52be41205bf656ed39658ff8cd1d3de5cc4ea09ce9694814e4149e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1992013370&rft_id=info:pmid/29373735&rft_oup_id=10.1093/nar/gky039&rfr_iscdi=true